Reference : Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
Scientific journals : Article
Human health sciences : Psychiatry
http://hdl.handle.net/2268/28132
Effect of previous antidepressant therapy on the growth hormone response to apomorphine.
English
Pitchot, William mailto [Centre Hospitalier Universitaire de Liège - CHU > > Psychiatrie et psychologie médicale >]
Hansenne, Michel mailto [Université de Liège - ULiège > Département des sciences cognitives > Psycho. de la personnalité et des différences individuelles >]
Gonzalez Moreno, A. [> > > >]
Ansseau, Marc mailto [Centre Hospitalier Universitaire de Liège - CHU > > Psychiatrie et psychologie médicale >]
1995
Neuropsychobiology
S. Karger
32
1
19-22
Yes (verified by ORBi)
0302-282X
1423-0224
Basel
Switzerland
[en] Adult ; Antidepressive Agents/adverse effects/therapeutic use ; Apomorphine/diagnostic use ; Depressive Disorder/blood/drug therapy ; Dopamine Agonists/diagnostic use ; Growth Hormone/blood ; Humans ; Male ; Psychiatric Status Rating Scales
[en] Several lines of evidence suggest a role for dopamine in the pathophysiology of depression. In 1988, we reported a blunted response of growth hormone (GH) to apomorphine, a dopaminergic agonist, in endogenous depression. However, an antidepressant washout period is a major confounding factor in studies assessing the GH response to apomorphine. Indeed, whereas the influence of tricyclic antidepressants on the GH response to apomorphine is presently unknown, several reports have suggested that tricyclics may impair the GH response to clonidine for periods longer than 3 weeks following their discontinuation. In the present study, we hypothesized that a blunted GH response to apomorphine in depressed patients could be related to the recent administration of antidepressants. Therefore, the GH response to apomorphine (0.5 mg) was studied in 11 male DSM-III-R major depressive inpatients who had never received antidepressant therapy (group 1) compared to 11 normal controls and 11 major depressive inpatients drug free for at least 2 weeks (group 2). The three groups differed significantly in the GH peak response to apomorphine: mean (SD) 5.4 (4.0) ng/ml in group 1, 25.5 (10.7) in normal controls, and 5.5 (5.1) in group 2 (F = 15.5, df = 3, 30, p = 0.00001). While group 1 and normal controls (F = 21.8, p = 0.0002) as well as group 2 and controls (F = 5.6, p = 0.03) differed significantly, group 1 and group 2 did not (F = 0.18, p = 0.68). These results suggest that a washout period of 2 weeks could be sufficient in studies assessing the GH response to apomorphine.
http://hdl.handle.net/2268/28132
10.1159/000119207

There is no file associated with this reference.

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.